Turn Medical

Executive Summary

Turn Medical is a privately held medical device company headquartered in Austin, Texas, dedicated to developing automated prone positioning solutions for critically ill patients suffering from respiratory distress, including Acute Respiratory Distress Syndrome (ARDS). Founded in 2018, the company addresses a significant clinical need: manual prone positioning, while highly effective for improving oxygenation, is labor-intensive, inconsistent, and carries risks of pressure injuries and accidental extubation. Turn Medical’s automated device aims to standardize and simplify this therapy, potentially improving patient outcomes and reducing the burden on healthcare providers. The COVID-19 pandemic highlighted the importance of prone positioning, yet adoption of automated solutions remains limited, presenting a strong market opportunity. With a focus on compassion and innovation, Turn Medical seeks to deliver a solution that enhances both clinical efficacy and patient safety. As of early 2026, the company has not disclosed revenue, funding, or regulatory clearances, suggesting it may still be in the development or early commercialization phase. Its profile indicates limited public data, and no commercial products have been confirmed. Nevertheless, the unmet need in respiratory critical care and the potential for technology-driven improvement position Turn Medical as a promising but early-stage player in the medical device space.

Upcoming Catalysts (preview)

• Q2 2027FDA 510(k) Clearance or CE Mark for Automated Prone Positioning Device40% success
• Q1 2027First-in-Human Clinical Study Results or Data Publication50% success
• Q4 2026Strategic Partnership or Series A/B Fundraising Announcement55% success